
Entact Bio CEO Victoria Richon
Entact Bio makes its Series A debut with $81M to launch protein enhancement platform
Entact Bio has secured $81 million in a Series A round to push forward its platform for developing therapies that can enhance the function of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.